Javascript must be enabled to continue!
Clinical Diagnosis of Probable Cerebral Amyloid Angiopathy: Diagnostic Accuracy Meta-Analysis of the Boston Criteria
View through CrossRef
Background:
The Boston criteria are used widely for the noninvasive diagnosis of sporadic cerebral amyloid angiopathy (CAA) and hence clinical decision-making, as well as research in the field. Yet, their exact diagnostic accuracy and validity remain (paradoxically) poorly studied. We performed a meta-analysis to synthesize evidence on the value and accuracy of the Boston criteria in diagnosing probable CAA patients.
Methods:
In a systematic literature search, we identified studies with extractable data relevant for sensitivity and specificity of probable CAA diagnosis per the magnetic resonance imaging Boston criteria and neuropathological CAA verification. We included studies that have classified patients according to any version of the Boston criteria, based on available brain magnetic resonance imaging blood-sensitive sequences (index test) and had neuropathologic evaluation for CAA presence from brain tissue samples (diagnostic reference standard). Using a hierarchical (multilevel) logistic regression model, we calculated pooled diagnostic test accuracy for probable CAA diagnosis.
Results:
Seven studies, including 193 patients, 121 with neuropathologically verified CAA versus 72 non-CAA based on neuropathology definition, were included in the meta-analysis. The studies were of low-to-moderate quality and varied in several methodological aspects. The overall pooled sensitivity for probable CAA diagnosis was 66.7% (95% CI, 45.9%–82.6%) and specificity was 88.2% (95% CI, 68.5%–96.3%). A predefined subgroup analysis of 4 studies on Boston criteria v.1.0 (n=151) demonstrated a pooled sensitivity and specificity of 60% (95% CI, 45.1%–72.9%) and 93.1% (95% CI, 81.8%–97.6%), respectively. Five studies had data on Boston criteria v.1.5 (n=123): the pooled sensitivity and specificity for probable CAA diagnosis was 73.1% (95% CI, 45%–90.1%) and 86% (95% CI, 41.4%–98.1%), respectively.
Conclusions:
The Boston criteria v.1.0 and v.1.5 appear to have moderate-to-good diagnostic accuracy for probable CAA in symptomatic patients, with high specificity but low-to-moderate sensitivity. Data are based on limited retrospective studies of overall low quality and at high risk of bias.
Title: Clinical Diagnosis of Probable Cerebral Amyloid Angiopathy: Diagnostic Accuracy Meta-Analysis of the Boston Criteria
Description:
Background:
The Boston criteria are used widely for the noninvasive diagnosis of sporadic cerebral amyloid angiopathy (CAA) and hence clinical decision-making, as well as research in the field.
Yet, their exact diagnostic accuracy and validity remain (paradoxically) poorly studied.
We performed a meta-analysis to synthesize evidence on the value and accuracy of the Boston criteria in diagnosing probable CAA patients.
Methods:
In a systematic literature search, we identified studies with extractable data relevant for sensitivity and specificity of probable CAA diagnosis per the magnetic resonance imaging Boston criteria and neuropathological CAA verification.
We included studies that have classified patients according to any version of the Boston criteria, based on available brain magnetic resonance imaging blood-sensitive sequences (index test) and had neuropathologic evaluation for CAA presence from brain tissue samples (diagnostic reference standard).
Using a hierarchical (multilevel) logistic regression model, we calculated pooled diagnostic test accuracy for probable CAA diagnosis.
Results:
Seven studies, including 193 patients, 121 with neuropathologically verified CAA versus 72 non-CAA based on neuropathology definition, were included in the meta-analysis.
The studies were of low-to-moderate quality and varied in several methodological aspects.
The overall pooled sensitivity for probable CAA diagnosis was 66.
7% (95% CI, 45.
9%–82.
6%) and specificity was 88.
2% (95% CI, 68.
5%–96.
3%).
A predefined subgroup analysis of 4 studies on Boston criteria v.
1.
0 (n=151) demonstrated a pooled sensitivity and specificity of 60% (95% CI, 45.
1%–72.
9%) and 93.
1% (95% CI, 81.
8%–97.
6%), respectively.
Five studies had data on Boston criteria v.
1.
5 (n=123): the pooled sensitivity and specificity for probable CAA diagnosis was 73.
1% (95% CI, 45%–90.
1%) and 86% (95% CI, 41.
4%–98.
1%), respectively.
Conclusions:
The Boston criteria v.
1.
0 and v.
1.
5 appear to have moderate-to-good diagnostic accuracy for probable CAA in symptomatic patients, with high specificity but low-to-moderate sensitivity.
Data are based on limited retrospective studies of overall low quality and at high risk of bias.
Related Results
Diagnostic Accuracies of Cerebral Amyloid Angiopathy Criteria in the First Thai Pathologically Confirmed Cohort
Diagnostic Accuracies of Cerebral Amyloid Angiopathy Criteria in the First Thai Pathologically Confirmed Cohort
Abstract
Backgrounds
The gold standard of cerebral amyloid angiopathy (CAA) diagnosis are surgical pathology or postmortem examination, which ar...
The Diagnostic Accuracy of the Refined EBMT Criteria 2023 for SOS
The Diagnostic Accuracy of the Refined EBMT Criteria 2023 for SOS
Introduction:
Sinusoidal obstruction syndrome (SOS) is a rare but serious complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT). An early...
Fine-Needle Aspiration Cytology and Salivary Gland Tumors: A Cross-Sectional Study
Fine-Needle Aspiration Cytology and Salivary Gland Tumors: A Cross-Sectional Study
Abstract
Introduction
Salivary gland neoplasms are relatively rare and diverse, requiring accurate preoperative diagnosis. Although the Milan System for Reporting Salivary Gland C...
Suffering of Patients with Neurogenic Thoracic Outlet Syndrome (TOS); The First Qualitative study in TOS
Suffering of Patients with Neurogenic Thoracic Outlet Syndrome (TOS); The First Qualitative study in TOS
Abstract
Background
Diagnosis of neurogenic thoracic outlet syndrome (nTOS) is hindered by symptom overlap with cervical radiculopathy, carpal tunnel syndrome, or psychosomatic dis...
Exploring Large Language Models Integration in the Histopathologic Diagnosis of Skin Diseases: A Comparative Study
Exploring Large Language Models Integration in the Histopathologic Diagnosis of Skin Diseases: A Comparative Study
Abstract
Introduction
The exact manner in which large language models (LLMs) will be integrated into pathology is not yet fully comprehended. This study examines the accuracy, bene...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract
Introduction
Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
Diagnostic accuracy of cerebral amyloid angiopathy criteria in the first pathologically confirmed Thai cohort: A pilot study
Diagnostic accuracy of cerebral amyloid angiopathy criteria in the first pathologically confirmed Thai cohort: A pilot study
Background: The gold standard for diagnosing cerebral amyloid angiopathy (CAA), full brain post-mortem examination, is rarely performed. Current diagnostic criteria, primarily base...
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...

